Deciphera Pharmaceuticals Inc (DCPH)
25.59 +0.02 (+0.08%) 06/11/24 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -194,942 | -178,931 | -299,964 | -266,489 | -192,256 |
| Depreciation Amortization | 2,100 | 2,946 | 3,014 | 2,305 | 830 |
| Accounts receivable | -9,345 | -1,784 | -6,699 | -13,896 | 0 |
| Accounts payable and accrued liabilities | 7,777 | 5,319 | 833 | -7,533 | 10,862 |
| Other Working Capital | -1,536 | -31,648 | 820 | -13,852 | 24,761 |
| Other Operating Activity | 49,249 | 51,236 | 61,172 | 59,782 | 6,507 |
| Operating Cash Flow | $-146,697 | $-152,862 | $-240,824 | $-239,683 | $-149,296 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 13,327 | -33,468 | 182,818 | 33,768 | -455,587 |
| PPE Investments | -778 | -841 | -1,970 | -5,309 | -4,935 |
| Other Investing Activity | 0 | 0 | -4,000 | 0 | 0 |
| Investing Cash Flow | $12,549 | $-34,309 | $176,848 | $28,459 | $-460,522 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,294 |
| Common Stock Issued | 152,638 | 165,419 | 14,930 | 227,616 | 438,288 |
| Other Financing Activity | -634 | -425 | -40 | -815 | -620 |
| Financing Cash Flow | $152,004 | $164,994 | $14,890 | $226,801 | $436,374 |
| Exchange Rate Effect | 910 | -145 | 252 | N/A | N/A |
| Beginning Cash Position | 64,741 | 87,063 | 135,897 | 120,320 | 293,764 |
| End Cash Position | 83,507 | 64,741 | 87,063 | 135,897 | 120,320 |
| Net Cash Flow | $18,766 | $-22,322 | $-48,834 | $15,577 | $-173,444 |
| Free Cash Flow | |||||
| Operating Cash Flow | -146,697 | -152,862 | -240,824 | -239,683 | -149,296 |
| Capital Expenditure | -778 | -841 | -1,970 | -5,316 | -4,935 |
| Free Cash Flow | -147,475 | -153,703 | -242,794 | -244,999 | -154,231 |